Compare DNTH & PVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DNTH | PVH |
|---|---|---|
| Founded | 2015 | 1881 |
| Country | United States | United States |
| Employees | 92 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 3.6B |
| IPO Year | 2018 | 1994 |
| Metric | DNTH | PVH |
|---|---|---|
| Price | $82.21 | $77.55 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 16 |
| Target Price | ★ $121.00 | $90.53 |
| AVG Volume (30 Days) | 909.4K | ★ 1.2M |
| Earning Date | 05-06-2026 | 06-03-2026 |
| Dividend Yield | N/A | ★ 0.16% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.90 |
| Revenue | $2,036,000.00 | ★ $8,950,200,000.00 |
| Revenue This Year | N/A | $1.89 |
| Revenue Next Year | $29.48 | $1.86 |
| P/E Ratio | ★ N/A | $40.23 |
| Revenue Growth | N/A | ★ 3.44 |
| 52 Week Low | $16.77 | $59.60 |
| 52 Week High | $96.50 | $100.75 |
| Indicator | DNTH | PVH |
|---|---|---|
| Relative Strength Index (RSI) | 47.09 | 40.20 |
| Support Level | $79.27 | $74.10 |
| Resistance Level | $92.41 | $79.91 |
| Average True Range (ATR) | 5.51 | 4.28 |
| MACD | -0.21 | -0.96 |
| Stochastic Oscillator | 54.28 | 25.39 |
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.
PVH designs and markets branded apparel in more than 40 countries. Its key fashion categories include men's dress shirts, ties, sportswear, underwear, and jeans. Its two designer brands, Calvin Klein and Tommy Hilfiger, now generate practically all its revenue after its recent disposition of most of its smaller brands. PVH operates e-commerce sites, roughly 1,400 standalone stores, and about 1,500 shop-in-shops and concessions. The firm also licenses its brands to third parties and distributes its merchandise through department stores and other wholesale accounts. PVH traces its history to 1881 and is based in New York City.